Hematology
12.8K views | +0 today
Follow
Hematology
Diagnosis, Therapy, Follow-up
Your new post is loading...
Your new post is loading...
Rescooped by Gilbert C FAURE from Cancer Pathways inhibitors Collection
Scoop.it!

BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib

Highlights

 

Olaparib monotherapy at clinical concentrations induces cell death in AML blasts.

AML blasts express undetectable BRCA1 protein.

PARP1 and γH2AX are biomarkers to identify the response of AML to olaparib.


Via Krishan Maggon
Krishan Maggon 's curator insight, May 10, 2015 2:56 AM

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Volume 1852, Issue 3, March 2015, Pages 462–472

 BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparibIsabella Faraonia, b, , , Mirco Compagnoneb, , Serena Lavorgnab, c, , Daniela Francesca Angelinid, , Maria Teresa Cencionid, , Eleonora Pirasd, , Paola Panettab, c, , Tiziana Ottoneb, c, , Susanna Dolcic, , Adriano Vendittic, , Grazia Graziania, 1, , Francesco Lo-Cocob, c, 1, doi:10.1016/j.bbadis.2014.12.001

Rescooped by Gilbert C FAURE from Cancer Pathways inhibitors Collection
Scoop.it!

Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia

Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia | Hematology | Scoop.it
Single-cell network profiling (SCNP) data generated from multi-parametric flow cytometry analysis of bone marrow (BM) and peripheral blood (PB) samples collected from patients >55 years old with non-M3 AML were used to train and validate a...

Via Krishan Maggon
Krishan Maggon 's curator insight, April 19, 2015 3:03 AM

Citation: Cesano A, Willman CL, Kopecky KJ, Gayko U, Putta S, et al. (2015) Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia. PLoS ONE 10(4): e0118485. doi:10.1371/journal.pone.0118485